NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Type 2 Diabetes mellitus
Date of first enrollment	20/01/2012
Target sample size	179
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : SYR-322 INN of investigational material : Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investigational material : 25 mg, once daily, orally control material(s) Generic name etc : Insulin INN of investigational material : Therapeutic category code : 249 Other hormone preparations (including antihormone preparations) Dosage and Administration for Investigational material : Dose adjustment, injection

Outcome(s)

Primary Outcome
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	Not applicable
Age maximum	Not applicable
Gender	Both
Include criteria	1. The subject is an outpatient. 2. The subject signs and dates a written, informed consent form and any required privacy authorization prior to the initiation of any study procedures.
Exclude criteria	1. The subject has any serious cardiac disease, serious cerebrovascular disorder, or any serious pancreatic or hematological disease. 2. The subject is considered ineligible for the study for any other reason by the investigator or subinvestigator.